On Monday evening, the laboratory specializing in the design and distribution of scientifically tested dietary supplements revealed that its Chinese joint venture, Hangzhou Valbiotis Life Health Technology, has established a subsidiary in Singapore.
The company stated that this move marks a key first step in the joint venture's deployment across Asia, extending beyond China and Hong Kong where it is already operational.
This new subsidiary will progressively target several strategic markets in the Asian region, including Singapore, Vietnam, Indonesia, and Japan.
According to Portzamparc, this announcement reflects the strong momentum of the Chinese joint venture. The brokerage firm noted that, regarding China, initial consumer sales are expected as early as the second half of 2026. Pending these first sales, analysts have not yet factored China into their financial modeling. The recommendation remains a 'buy' on Valbiotis shares, with a price target of 2.70 euros, representing a 190% upside potential compared to Monday's close.
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
-
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
-
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
-
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
